000 07152cam a2200493Ii 4500
999 _c96650
_d96650
_x1
001 96650
003 ES-MaUEC
005 20230102112804.0
006 m o d
007 cr cnu---unuuu
008 171101s2017 sz a o 001 0 eng d
020 _a3319660942
020 _a3319660950
_q(electronic bk.)
020 _a9783319660943
020 _a9783319660950
_q(electronic bk.)
020 _z9783319660943
_q(print)
040 _aGW5XE
_beng
_erda
_epn
_cGW5XE
_dN$T
_dEBLCP
_dUAB
_dAZU
_dOCLCF
_dUPM
_dIOG
_dCOO
_dOCLCQ
_dVT2
_dCASUM
_dOCLCO
_dMERER
_dES-MaUEC
_bspa
050 4 _aQP552.P4
_b2017 EB
245 0 0 _aPeptides and peptide-based biomaterials and their biomedical applications
_cAnwar Sunna, Andrew Care, Peter L. Bergquist, editors.
264 1 _aCham, Switzerland
_bSpringer International Publishing
_c2017
300 _a1 recurso en línea (xiii, 300 páginas)
_bilustraciones (algunas a color)
336 _aTexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
347 _atext file
_bPDF
490 0 _aAdvances in experimental medicine and biology
_x0065-2598
_vvolume 1030
500 _aIncludes index.
500 _a
505 0 _a""Preface""; ""Contents""; ""About the Editors""; ""1: Programmable Bio-surfaces for Biomedical Applications""; ""1.1 Introduction""; ""1.2 Sources of Peptide""; ""1.2.1 Natural Peptide""; ""1.2.2 Peptide Derived from Natural Protein""; ""1.2.3 Artificial Peptide""; ""1.3 Functions of Peptides""; ""1.4 Immobilization Methods""; ""1.4.1 Physical Adsorption""; ""1.4.2 SAM-Based Immobilization""; ""1.4.3 Polymer-Based Immobilization""; ""1.4.4 Aptamer-Based Immobilization""; ""1.5 Utilization of Programmable Bio-surfaces""; ""1.6 Conclusions""; ""References""
505 8 _a""2: Solid-Binding Peptides in Biomedicine""""2.1 Introduction""; ""2.1.1 SBP Binding and Synthesis Mechanisms""; ""2.1.2 Isolation of SBPs""; ""2.2 Applications in Biomedicine""; ""2.2.1 Vaccine Development""; ""2.2.2 Bioimaging""; ""2.2.3 Drug Delivery""; ""2.2.4 LPG â#x80;#x93; Cell Capture""; ""2.2.5 Biocompatibility""; ""2.2.6 Biomedical Diagnostics""; ""2.2.7 Anti-microbial Therapeutics""; ""2.2.8 Surgical Implants and Biomaterials for Biomedicine""; ""2.3 Concluding Remarks and Future Perspectives""; ""References""
505 8 _a""3: Molecular Modelling of Peptide-Based Materials for Biomedical Applications""""3.1 Introduction""; ""3.2 Hydroxyapatite-Based Materials""; ""3.2.1 Progress in Molecular Simulations of the Peptide-HAp Interface""; ""3.2.2 Outlook for Molecular Simulations of the Peptide-HAp Interface""; ""3.3 Titania-Based Materials""; ""3.3.1 Progress in Molecular Simulations of the Peptide-Titania Interface""; ""3.3.2 Outlook for Molecular Simulations of the Peptide-Titania Interface""; ""3.4 Outlook and Future Prospects""; ""References""
505 8 _a""4.3.2.1 14-Helix""""4.3.2.2 12-Helix""; ""4.3.2.3 10-Helix, 10/12 or 12/10-Helix""; ""4.3.2.4 8-Helix""; ""4.3.2.5 C6-Ribbon""; ""4.3.2.6 β Sheet-Like Structures (Parallel Sheets)""; ""4.3.3 Peptoids""; ""4.3.4 Hybrid α/β Peptides""; ""4.4 Factors Affecting β-Peptide Folding""; ""4.5 Self-Assembled Oligopeptide Superstructures""; ""4.6 Engineering Unnatural Supramolecular Structures""; ""4.6.1 Amphiphiles Based on α-Peptides""; ""4.6.2 Self-Assembly of α-Helical Building Blocks""; ""4.6.3 Amphiphiles Based on β-Peptides""
505 8 _a""4: Design Principles of Peptide Based Self-Assembled Nanomaterials""""4.1 Introduction""; ""4.2 Self-Assembly""; ""4.2.1 Interactions That Drive Self-Assembly""; ""4.2.1.1 Hydrogen Bonding""; ""4.2.1.2 Van der Waals Interactions""; ""4.2.1.3 Solvophobic Interactions""; ""4.2.1.4 Electrostatic Interactions""; ""4.2.1.5 Aromatic Interactions (Ï#x80;-Ï#x80; Stacking)""; ""4.3 Bioinspired Building Blocks of Self-Assembly""; ""4.3.1 Secondary Structures of α-Peptides""; ""4.3.1.1 β-Sheet""; ""4.3.1.2 α-Helix""; ""4.3.1.3 310 Helix""; ""4.3.2 Secondary Structures of β-Peptides""
520 3 _aThis edited volume is composed of chapters written by experts in the field describing fundamental research on small peptide fragments in relation to their biological action and potential roles in biomedical applications from diagnosis to implant protection. It provides a review of the wide scope and significance of these relatively simple arrays of amino acids that have the ability to bind to surfaces of all kinds and can facilitate the autonomous assembly of structures in nanotechnology as well as penetrating cell membranes and delivering therapeutic drugs. Readers will learn of some of the impediments to a wider and more comprehensive catalog of these molecules and of some of the attributes of rationally-designed and chemically synthesised peptides as anticancer agents. An overview is provided of the expansive variety of biological leads for biomedically relevant peptides as well as the wide array of tissues and biological, bioactive scaffolds that are dependent on these short peptide sequences addressing topics such as cartilage and hard tissue initiation and regeneration and the transition of active reagents from molluscs to drug leads for the treatment of chronic pain. Peptides can possess surface-specific non-covalent adsorption properties that can be exploited to enhance the functionality of medical implant materials but their implementation is largely on a trial-and-error basis because an understanding of general structure/function relationships is lacking. Molecular simulation approaches can provide relevant details at the atomic scale and prospects for advancing peptide-mediated medical implant surface treatments via molecular simulation are summarized. The literature has papers emphasizing the role of peptides in the design of biohybrid functional surfaces and there has been a growing interest in applying peptides as materials-selective assemblers and self-organizers, but applications are based largely on an empirical understanding of solid surface binding characteristics, as reviewed here. The present work is written for researchers who may be considering entering this field and are exposed to a mass of fundamental research information on individual applications. It has been our intention to trace how and where the research has emerged and to outline the opportunities we see to develop novel and well-grounded tools for specific therapeutic scenarios.
588 0 _aOnline resource; title from PDF title page (EBSCO, viewed November 1, 2017).
988 _aEBOOK, EBSPRINGER_2017
650 7 _aPéptidos
_xBiotechnology.
_2embne
_0(OCoLC)fst01057566
_9146243
_0LocalZ
700 1 _aBergquist, Peter L.,
_eeditor literario
700 1 _aCare, Andrew,
_eeditor literario
700 1 _aSunna, Anwar,
_eeditor literario
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-66095-0
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
998 _b02/2018
_dz
_e-
_zSI